ClinicalTrials.Veeva
Menu

Find clinical trials for Multiple Sclerosis (MS) in Atlanta, GA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Sclerosis
Multiple Sclerosis
Relapsing-Remitting Multiple Sclerosis
Chronic Progressive Multiple Sclerosis
Amyotrophic Lateral Sclerosis
Motor Neuron Disease
Muscle Spasticity

Multiple Sclerosis (MS) trials near Atlanta, GA, USA:

Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis (NEOS)

Efficacy and safety of ofatumumab and siponimod compared to fingolimod in pediatric patients with multiple sclerosis...

Enrolling
Multiple Sclerosis (MS)
Other: Ofatumumab placebo
Drug: Siponimod

Phase 3

Novartis
Novartis

Atlanta, Georgia, United States and 73 other locations

with Parkinson's disease (PD), essential tremor (ET), dystonia or multiple sclerosis (MS). These data will guide the desig...

Invitation-only
Multiple Sclerosis
Essential Tremor
Procedure: Symptogenic Stimulation Patterns
Procedure: Therapeutic Stimulation Patterns
Duke University
Duke University

Atlanta, Georgia, United States and 2 other locations

Open-label study to evaluate the effectiveness of treatment with ofatumumab in subjects transitioning from any fumarate-based RMS approved therapy or...

Active, not recruiting
Relapsing Multiple Sclerosis
Biological: Ofatumumab

Phase 3

Novartis
Novartis

Atlanta, Georgia, United States and 122 other locations

This study will evaluate the impact of ofatumumab in Relapsing Remitting Multiple Sclerosis (RRMS) participants that are very early...

Active, not recruiting
Relapse Remitting Multiple Sclerosis
Drug: Ofatumumab

Phase 4

Novartis
Novartis

Knoxville, Tennessee, United States and 35 other locations

To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)...

Enrolling
Relapsing Multiple Sclerosis
Drug: Remibrutinib
Drug: Teriflunomide

Phase 3

Novartis
Novartis

Suwanee, Georgia, United States and 229 other locations

This is a randomized, double-blind study of PIPE-307 or placebo in subjects with relapsing-remitting multiple sclerosis. Subjects w...

Enrolling
Relapsing Remitting Multiple Sclerosis
Drug: Placebo
Drug: PIPE-307 Dose B

Phase 2

Contineum Therapeutics

Knoxville, Tennessee, United States and 24 other locations

This is a Phase 1 study of IMS001, given as a single dose to subjects with Multiple Sclerosis who experience inadequate response an...

Enrolling
Multiple Sclerosis
Biological: IMS001

Phase 1

ImStem Biotechnology

Atlanta, Georgia, United States and 2 other locations

American (AA) and Hispanic/Latino (HA) patients with relapsing multiple sclerosis (RMS) receiving treatment with Ocrelizumab. The s...

Active, not recruiting
Multiple Sclerosis, Relapsing
Drug: Ocrelizumab

Phase 4

Genentech
Genentech

Atlanta, Georgia, United States and 30 other locations

Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients with Progressive Multiple...

Active, not recruiting
Multiple Sclerosis
Drug: Placebo matching IMU-838
Drug: IMU-838

Phase 2

Immunic Therapeutics

Ormond Beach, Florida, United States and 72 other locations

The ALSpire Study is a clinical trial evaluating the investigational drug BIIB105 in adults living with amyotrophic lateral sclerosis (ALS)....

Active, not recruiting
Amyotrophic Lateral Sclerosis
Drug: Placebo
Drug: BIIB105

Phase 1, Phase 2

Biogen
Biogen

Atlanta, Georgia, United States and 16 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems